3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
8
Neoplasms
6
Leukemia
5
Neoplasms by Histologic Type
4
Myeloproliferative Disorders
4
Leukemia, Myeloid
4
Hematologic Diseases
4
Carcinoma, Non-Small-Cell Lung
4
Bone Marrow Diseases
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Lymphoproliferative Disorders
2
Lymphatic Diseases
2
Leukemia, Myeloid, Chronic-Phase
2
Immunoproliferative Disorders
2
Immune System Diseases
2
Thyroid Neoplasms
1
Small Cell Lung Carcinoma
1
Piebaldism
1
Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL)
1
Malignant Hepatobiliary Neoplasm
1
Lung Neoplasms
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Acute
1
Head and Neck Neoplasms
1
Glioblastoma
1
Gastrointestinal Stromal Tumors
1
Gastrointestinal Neoplasms
1
Carcinoma, Squamous Cell
1
Blast Crisis
1
Adenocarcinoma of Lung
1
Interventions
Imatinib Mesylate
5
nilotinib
4
bosutinib
3
asciminib
2
peginterferon alfa-2a
1
fludarabine phosphate
1
fludarabine
1
Magnetic Resonance Imaging
1
Electrocardiography
1
Echocardiography
1
Diphenhydramine
1
Dasatinib
1
Cyclophosphamide
1
Blood Component Removal
1
Antiemetics
1
Acetaminophen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Philadelphia Chromosome
×
ponatinib
×
Clear all
No trials found.